Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 8 November

Sophia Mavridis
November 8, 2021

Weekly Wrap 5 November

Sophia Mavridis
November 5, 2021

Morning Bell 4 November

Paulina Peters
November 4, 2021

Morning Bell 3 November

Sophia Mavridis
November 3, 2021

Morning Bell 2 November

Paulina Peters
November 2, 2021

Morning Bell 1 November

Sophia Mavridis
November 1, 2021

Weekly Wrap 29 October

Sophia Mavridis
October 29, 2021

Morning Bell 28 October

Paulina Peters
October 28, 2021

Morning Bell 27 October

Sophia Mavridis
October 27, 2021

Morning Bell 26 October

Paulina Peters
October 26, 2021

Morning Bell 25 October

Sophia Mavridis
October 25, 2021

Weekly Wrap 22 October

Sophia Mavridis
October 22, 2021